NM_181715.3:c.1626T>G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181715.3(CRTC2):c.1626T>G(p.His542Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181715.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRTC2 | ENST00000368633.2 | c.1626T>G | p.His542Gln | missense_variant | Exon 12 of 14 | 1 | NM_181715.3 | ENSP00000357622.1 | ||
CRTC2 | ENST00000461638.6 | n.1386T>G | non_coding_transcript_exon_variant | Exon 10 of 13 | 1 | ENSP00000434115.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1626T>G (p.H542Q) alteration is located in exon 12 (coding exon 12) of the CRTC2 gene. This alteration results from a T to G substitution at nucleotide position 1626, causing the histidine (H) at amino acid position 542 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.